It sounds like a good idea , writes KPMG CEO John Gilmore on the Forbes blog . A drug thought to be effective enough to reduce the overall cost of care for patients should be priced lower .
It sounds like a good idea, writes KPMG analyst Peter Gilmore on the Forbes blog. A drug proven to be effective enough to lower the overall costs of care for patients should be priced lower.